Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Novel AlCl3 catalyzed route for prucalopride intermediate. High yield, safe scale-up, cost-effective manufacturing for global supply chains.
Patent CN106478439B reveals a high-yield organic acid catalyzed route for pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for insulin manufacturing.
Novel slurry purification method controls 2-ethylpentanoic acid impurity ensuring European Pharmacopoeia compliance and supply chain stability for pharmaceutical intermediates.
Novel catalyst-free method improves yield and safety for benzimidazole derivatives, offering cost-effective supply chain solutions.
Novel synthesis route offers high yield and safety for finafloxacin intermediate production. Reduces toxic waste and ensures supply chain stability for global pharmaceutical manufacturers seeking reliable partners.
Novel nickel-catalyzed cyanation route for high-purity pharma intermediates. Delivers significant cost reduction in pharma manufacturing and reliable supply chain continuity.
Patent CN109678797A reveals a one-pot method for ABA agonists. This reduces steps and improves supply chain reliability for agrochemical intermediate manufacturing globally.
Novel Pd-catalyzed C-H methylation method for ortho-methyl aryl formic acid derivatives. Offers mild conditions, air atmosphere, and scalable synthesis for pharmaceutical intermediates.
Patent CN110105201B details a high-purity synthesis route for R-(+)-2-(4-hydroxyphenoxy)propionic acid, offering significant cost reduction and supply chain reliability for herbicide manufacturers.
Patent CN100546969C details a cost-effective resolution method for 2-hydroxymethyl-3-phenylpropionic acid using N-Octylglucamine, offering high optical purity for pharmaceutical synthesis.
Patent CN111004089B reveals efficient one-step decarboxylation. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN109438168B details a novel BrCl bromination method for bromopentafluorobenzene, offering superior atom economy and cost reduction for fine chemical manufacturing.
Patent CN111303047B reveals a high-yield synthesis of 2-amino-4,6-lutidine from 3-aminocrotonenitrile, offering superior purity and cost-effective manufacturing for global supply chains.
Novel atmospheric pressure Grignard route for DHTA monomer production offering high purity and reduced operational complexity for polymer manufacturers.
Novel Cu-catalyzed click chemistry route for 1,2,3-triazole cinnamic acids. Offers mild conditions and high selectivity for scalable pharmaceutical intermediate manufacturing.
Novel synthesis route for pharmaceutical intermediates reducing costs and improving supply chain reliability for global buyers seeking high purity materials.
Patent CN102060694B reveals a cost-effective route for pyrethroid intermediates using direct dehydrohalogenation, offering significant supply chain advantages.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN101805389A details a novel 3-step semi-synthetic route for Corosolic Acid from Ursolic Acid, offering >98% purity and significant cost reduction for pharmaceutical manufacturing.